New! Sign up for our free email newsletter.
Science News
from research organizations

Use of osteoporosis drug with anti-inflammatory medication linked to lower risk of hip fracture

Date:
July 11, 2017
Source:
The JAMA Network Journals
Summary:
Among older patients using medium to high doses of the anti-inflammatory steroid prednisolone, treatment with the osteoporosis drug alendronate was associated with a significantly lower risk of hip fracture, according to a study.
Share:
FULL STORY

Among older patients using medium to high doses of the anti-inflammatory steroid prednisolone, treatment with the osteoporosis drug alendronate was associated with a significantly lower risk of hip fracture, according to a study published by JAMA.

Although glucocorticoid therapy is widely used to treat inflammatory conditions, it can lead to rapid bone loss and is associated with an increased rate of fracture. Evidence is lacking regarding the efficacy of alendronate to protect against hip fracture in older patients using glucocorticoids. Using a national database, Mattias Lorentzon, M.D., Ph.D., of the University of Gothenburg, Sweden, and colleagues identified 1,802 patients who were prescribed alendronate after at least 3 months of oral prednisolone treatment, and 1,802 patients taking prednisolone without alendronate use.

The average age of the patients was 80 years; 70 percent were women. After a median follow-up of 1.3 years, there were 27 hip fractures in the alendronate group and 73 in the no-alendronate group. Analyses indicated that alendronate treatment for a median duration of 2.9 years was associated with lower risk of hip fracture than no alendronate treatment. Greater duration of treatment was associated with a lower risk of hip fracture.

"Although the findings are limited by the observational study design and the small number of events, these results support the use of alendronate in this patient group," the authors write.


Story Source:

Materials provided by The JAMA Network Journals. Note: Content may be edited for style and length.


Journal Reference:

  1. Kristian F. Axelsson, Anna G. Nilsson, Hans Wedel, Dan Lundh, Mattias Lorentzon. Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone. JAMA, 2017; 318 (2): 146 DOI: 10.1001/jama.2017.8040

Cite This Page:

The JAMA Network Journals. "Use of osteoporosis drug with anti-inflammatory medication linked to lower risk of hip fracture." ScienceDaily. ScienceDaily, 11 July 2017. <www.sciencedaily.com/releases/2017/07/170711112500.htm>.
The JAMA Network Journals. (2017, July 11). Use of osteoporosis drug with anti-inflammatory medication linked to lower risk of hip fracture. ScienceDaily. Retrieved March 28, 2024 from www.sciencedaily.com/releases/2017/07/170711112500.htm
The JAMA Network Journals. "Use of osteoporosis drug with anti-inflammatory medication linked to lower risk of hip fracture." ScienceDaily. www.sciencedaily.com/releases/2017/07/170711112500.htm (accessed March 28, 2024).

Explore More

from ScienceDaily

RELATED STORIES